J-Pharma Co Ltd Pipeline Insight and Competitive Landscape, 2024
Powered by ![]()
Unlock hidden opportunities in the Medical Devices industry
Empower your strategies with our J-Pharma Co Ltd Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions.
J-Pharma Co Ltd (J-Pharma) is a pharmaceutical company that develops original inhibitors of L-type amino acid transporter 1 (LAT1) for the treatment of advanced cancer. The company’s products portfolio includes namburrat, OKY-034, LAT1 inhibitor, NKO-028 and 035. It offers drugs for various cancers which include biliary tract cancer, pancreatic cancer, solid cancer and autoimmune disease in the form intravenous injection and oral administration. The company also carries out different phases of clinical trails. J-Pharma is headquartered in Yokohama, Kanagawa, Japan.
GlobalData’s Medical Devices company profile report, “J-Pharma Co Ltd Pipeline Insight and Competitive Landscape, 2024″ provides information about the company overview and analysis on their pipeline products.
This company profile report provides key information and data related to:
- Top level information about the company performance and their pipeline products
- Review details of major pipeline products which include developmental activities including pipeline territories, and estimated approval dates
This company profile report enables you to:
- Access significant analysis and insights to improve R&D strategies
- Formulate market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.
The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business.
For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Scope
- Market share
- Product portfolio
- Subsidiaries
- Revenue
- Pipeline products overview
- Sector analysis
- Approval timeline for pipeline products
- Pipeline products by geography
- Pipeline products by various stages of development
Reasons to Buy
- Strategic Positioning: Gain insights into J-Pharma Co Ltd’s market share, revenue and subsidiaries.
- Strategic Alignment: Analyse the diverse product portfolio to align your strategies with industry trends.
- Strategic Navigation: Navigate the medical devices sector with in-depth sector analysis along with pipeline products and their approval timeline and geographical distribution.
Key Players
Frequently asked questions
Related reports
View more Medical Devices reports